Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2025 08:47 ET | Source: Société Générale

Societe Generale offer to purchase certain of its debt securities

SOCIETE GENERALE OFFER TO PURCHASE CERTAIN OF ITS DEBT SECURITIES Press release Paris, April 1, 2025 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN...
April 01, 2025 07:39 ET | Source: Research and Markets

$2.3 Bn Viral Vector, Non-Viral Vector and Gene Therapy Manufacturing Markets, 2035 - Viral Vectors Gain Traction with 30+ Approvals and 200+ Gene Therapies in U.S. Clinical Trials

Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by...
April 01, 2025 07:30 ET | Source: Korro Bio, Inc.

Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer

CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based...
April 01, 2025 07:30 ET | Source: Nexxen International Ltd.

Nexxen Announces March 2025 Share Repurchase Program Summary

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and...
March 31, 2025 16:20 ET | Source: Vivos Therapeutics, Inc

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
March 31, 2025 12:21 ET | Source: SOCIETE GENERALE SFH

Availability of the Annual Financial Report of Societe Generale SFH for 2024

SOCIETE GENERALE SFH: AVAILABILITY OF THE ANNUAL FINANCIAL REPORT FOR 2024 Regulated Information Paris, 31 March 2025 Societe Generale SFH (“Société de Financement de l’Habitat”, Home Loans SFH)...
March 31, 2025 12:01 ET | Source: SOCIETE GENERALE SCF

Availability of the Annual Financial Report of Societe Generale SCF for 2024

SOCIETE GENERALE SCF: AVAILABILITY OF THE ANNUAL FINANCIAL REPORT FOR 2024 Regulated Information Paris, 31 March 2025 Societe Generale SCF (“Société de Crédit Foncier”, Public Sector Loans) hereby...
March 31, 2025 11:48 ET | Source: Société Générale

Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement)

INFORMATION REGARDING EXECUTED TRANSACTIONS WITHIN THE FRAMEWORK OF A SHARE BUYBACK PROGRAM (OUTSIDE THE LIQUIDITY AGREEMENT) Regulated Information Paris, 31 March 2025 (In accordance with article...
March 31, 2025 10:00 ET | Source: Tenaya Therapeutics, Inc.

Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting

TN-201 Has Been Well Tolerated at 3E13 vg/kg Dose New Biopsy Data Reaffirm Robust Transduction and RNA Expression with TN-201; RNA and Protein Levels Increase Over Time All Cohort 1 Patients...
March 31, 2025 09:30 ET | Source: Trethera Corporation

Trethera Treats a Late Stage, Heavily Pretreated Amyotrophic Lateral Sclerosis (ALS) Patient with TRE 515

LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune diseases through...